---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-095136"
form_type: "8-K"
ticker: "VCNX"
cik: "0001205922"
company_name: "VACCINEX, INC."
filed_at: "2022-04-04T23:59:59+00:00"
generated_at: "2026-06-26T09:42:53.222882+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Vaccinex grants stock options and 7% salary increases to top executives

## Summary
- CEO Maurice Zauderer receives options for 28,000 shares at $1.29, vesting over 4 years.
- CSO Ernest Smith gets options for 20,000 shares; CFO Scott Royer gets 16,000 shares at same price.
- Base salaries raised 7%: Zauderer to $406,600, Smith to $287,981, Royer to $262,223.
- Options granted under 2018 Omnibus Incentive Plan, expire 10 years from grant date April 1, 2022.

## SEC filing metadata
- accession: 0001193125-22-095136
- form_type: 8-K
- ticker: VCNX
- cik: 0001205922
- company_name: VACCINEX, INC.
- filed_at: 2022-04-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1205922/000119312522095136/0001193125-22-095136-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1205922/000119312522095136/d325737d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-095136
- JSON: https://secwatch.observer/filing/0001193125-22-095136.json
- Plain text: https://secwatch.observer/filing/0001193125-22-095136.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.